Sagimet Biosciences to Host Virtual Investor and Analyst Day

SAN MATEO, Calif., May 16, 2024 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Sagimet, Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel fatty acid synthase (FASN) inhibitors designed to target dysfunctional

Related Keywords

Israel , Barcelona , Comunidad Autonoma De Cataluna , Spain , Shanghai , China , United States , Boston , Massachusetts , Germany , American , Joyce Allaire , Scottl Friedman , Sagimet Biosciences , Moshe Oren , Alpha Omega Honor Society , Weizmann Institute Of Science , International Hans Popper Award , Exchange Commission , Harvard Medical School , American Liver Foundation , American College Of Physicians , Falk Foundation In Freiburg , Sagimet Biosciences Inc , American Gastroenterological Association , American Association For The Advancement Science , Division Of Liver Diseases , Icahn School Of Medicine At Mount Sinai , Division Of Liver Diseases At Mount Sinai , Nasdaq , Icahn School , Mount Sinai , Therapeutic Discovery , Liver Diseases , Medical Resident , Beth Israel Hospital , Gastroenterology Fellowship , Senior Fulbright Scholar , Visiting Professor , Weizmann Institute , Professor Moshe , Falk Foundation , European Association , Liver Diseases International Recognition Award , Shanghai Magnolia Gold Award , China Friendship Award , Distinguished Achievement Awards , American Liver , American College , American Association , Private Securities Litigation Reform Act ,